Myocardial perfusion imaging in Takayasu arteritis

Journal of Rheumatology

Volumn 40, Issue 12, 2013, Pages 2052-2060

  Comarmond, Cloé ^a   Dessault, Odile ^b   Devaux, Jean Yves ^b   Costedoat Chalumeau, Nathalie ^a   Resche Rigon, Matthieu ^c   Isnard, Richard ^a   Koskas, Fabien ^a   Cacoub, Patrice ^a   Saadoun, David ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

Microcirculation; Myocardial ischemia; Scintigraphy; Takayasu arteritis; Vasculitis

Indexed keywords

DIPYRIDAMOLE; THALLIUM 201;

ADULT; AORTA ARCH SYNDROME; AORTA RECONSTRUCTION; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HEART MUSCLE FIBER MEMBRANE STEADY POTENTIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RENOVASCULAR HYPERTENSION;

MICROCIRCULATION; MYOCARDIAL ISCHEMIA; SCINTIGRAPHY; TAKAYASU ARTERITIS; VASCULITIS;

ADULT; AORTIC VALVE INSUFFICIENCY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; PROSPECTIVE STUDIES; RISK FACTORS; TAKAYASU ARTERITIS; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 84889016709     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130308     Document Type: Article

References (44)

1. Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.
2. Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors. Circulation 1994;90:1855-60.
3. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 1977;93:94-103.
4. Lee GY, Jang SY, Ko SM, Kim EK, Lee SH, Han H, et al. Cardiovascular manifestations of Takayasu arteritis and their relationship to the disease activity: analysis of 204 Korean patients at a single center. Int J Cardiol 2012;159:14-20.
5. Keenan NG, Mason JC, Maceira A, Assomull R, O'Hanlon R, Chan C, et al. Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. Arthritis Rheum 2009;60:3501-9.
6. Nishimura T, Matsuo T, Uehara T, Hayashida K, Kozuka T, Nakayama R. Exercise thallium scintigraphy in aortitis syndrome (Takayasu's arteritis). Eur J Nucl Med 1990;16:173-8.
7. Hashimoto Y, Numano F, Maruyama Y, Oniki T, Kasuya K, Kakuta T, et al. Thallium-201 stress scintigraphy in Takayasu arteritis. Am J Cardiol 1991;67:879-82.
8. Breinholt JP 3rd, Tristani-Firouzi M, Bohnsack JF, Shaddy RE. Evidence for early vessel involvement in the dysfunctional myocardium of Takayasu's arteritis. Pediatr Cardiol 2001;22:74-6.
9. Takeda N, Takahashi T, Seko Y, Maemura K, Nakasone H, Sakamoto K, et al. Takayasu myocarditis mediated by cytotoxic T lymphocytes. Intern Med 2005;44:256-60.
10. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990;33:1129-34.
11. Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 1996; 54:S155-63.
12. Nishimura T, Uehara T, Hayashida K, Kozuka T. Coronary arterial involvement in aortitis syndrome: assessment by exercise thallium scintigraphy. Heart Vessels Suppl 1992;7:106-10.
13. Leppo J, Boucher CA, Okada RD, Newell JB, Strauss HW, Pohost GM. Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion. Circulation 1982;66:649-57.
14. Beller GA. Dipyridamole thallium-201 scintigraphy: an excellent alternative to exercise scintigraphy. J Am Coll Cardiol 1989;14:1642-4.
15. Schaper W. Dipyridamole, an underestimated vascular protective drug. Cardiovasc Drugs Ther 2005;19:357-63.
16. Kurtoglu N, Akcay A, Dindar I. Usefulness of oral dipyridamole therapy for angiographic slow coronary artery flow. Am J Cardiol 2001;87:777-9.
17. Kahan A, Devaux JY, Amor B, Menkes CJ, Weber S, Foult JM, et al. Pharmacodynamic effect of dipyridamole on thallium-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma. Ann Rheum Dis 1986;45:718-25.
18. Kahan A, Devaux JY, Amor B, Menkès CJ, Weber S, Nitenberg A, et al. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med 1986;314:1397-402.
19. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
20. Ortiz-Pérez JT, Rodríguez J, Meyers SN, Lee DC, Davidson C, Wu E. Correspondence between the 17-segment model and coronary arterial anatomy using contrast-enhanced cardiac magnetic resonance imaging. JACC Cardiovasc Imaging 2008;1:282-293.
21. Soto ME, Meléndez-Ramírez G, Kimura-Hayama E, Meave-Gonzalez A, Achenbach S, Herrera MC, et al. Coronary CT angiography in Takayasu arteritis. JACC Cardiovasc Imaging 2011;4:958-66.
22. Tellier P, Valeyre D, Nitenberg A, Foult JM, Bedig G, Battesti JP. Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med 1985;11:201-4.
23. Tellier P, Paycha F, Antony I, Nitenberg A, Valeyre D, Foult JM, et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 1988;85:189-93.
24. Mousa AR, Marafie AA, Dajani AI. Cutaneous necrotizing vasculitis complicating Takayasu's arteritis with a review of cutaneous manifestations. J Rheumatol 1985;12:607-10.
25. Skaria AM, Ruffieux P, Piletta P, Chavaz P, Saurat JH, Borradori L. Takayasu arteritis and cutaneous necrotizing vasculitis. Dermatology 2000;200:139-43.
26. Malik KP, Kapoor K, Mehta A, Dadeya S, Guliani BP, Aggarwal S, et al. Bilateral anterior ischaemic optic neuropathy in Takayasu arteritis. Indian J Ophthalmol 2002;50:52-4.
27. Schmidt MH, Fox AJ, Nicolle DA. Bilateral anterior ischemic optic neuropathy as a presentation of Takayasu's disease. J Neuroophthalmol 1997;17:156-61.
28. Conrath J, Hadjadj E, Serratrice J, Ridings B. Direction occlusion veineuse rétinienne révèle la maladie de Takayasu (French). Branch retinal vein occlusion reveals Takayasu's arteritis. J Fr Ophtalmol 2004;27:162-5.
29. Kaushik S, Gupta A, Gupta V, Jain S, Lal V. Retinal arterial occlusion in Takayasu's arteritis. Indian J Ophthalmol 2005; 53:194-6.
30. Pfeil A, Lehmann G, Böttcher J, Wolf G, Hansch A. The role of first-pass perfusion deficit in the detection of cardiac subendocardial manifestation in patients with autoimmune vasculitis. Rheumatol Int 2013;33:29-35.
31. Hansch A, Pfeil A, Rzanny R, Neumann T, Kaiser WA. First-pass myocardial perfusion abnormalities in Churg-Strauss syndrome with cardiac involvement. Int J Cardiovasc Imaging 2009;25:501-10.
32. Seko Y, Minota S, Kawasaki A, Shinkai Y, Maeda K, Yagita H, et al. Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis. J Clin Invest 1994;93:750-8.
33. Numano F, Isohisa I, Maezawa H, Juji T. HL-A antigens in Takayasu's disease. Am Heart J 1979;98:153-9.
34. Kasuya K, Hashimoto Y, Numano F. Left ventricular dysfunction and HLA Bw52 antigen in Takayasu arteritis. Heart Vessels Suppl 1992;7:116-9.
35. Ishida R, Murata Y, Sawada Y, Nishioka K, Shibuya H. Thallium-201 myocardial SPET in patients with collagen disease. Nucl Med Commun 2000;21:729-34.
36. Sacré K, Brihaye B, Hyafil F, Serfaty J-M, Escoubet B, Zennaro M-C, et al. Asymptomatic myocardial ischemic disease in antiphospholipid syndrome: a controlled cardiac magnetic resonance imaging study. Arthritis Rheum 2010;62:2093-100.
37. Murata Y, Yamada I, Umehara I, Shibuya H. Tl-201 myocardial SPECT in patients with systemic arterial diseases. Clin Nucl Med 1998;23:832-5.
38. Ishimori ML, Martin R, Berman DS, Goykhman P, Shaw LJ, Shufelt C, et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. JACC Cardiovasc Imaging 2011;4:27-33.
39. Okayama K, Kurata C, Tawarahara K, Wakabayashi Y, Chida K, Sato A. Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest 1995;107:330-4.
40. Dennert RM, van Paassen P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, et al. Cardiac involvement in Churg-Strauss syndrome. Arthritis Rheum 2010;62:627-34.
41. Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1, 012 Italian patients. Medicine 2002;81:139-53.
42. Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine 2011;90:19-27.
43. Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y. Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn 1993;43:372-6.
44. Kahan A, Nitenberg A, Foult JM, Amor B, Menkes CJ, Devaux JY, et al. Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum 1985;28:637-46.